Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
-
SUSE Rancher Prime Innovations Advance Enterprises’ Cloud Native Strategies
-
Corvus Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial of Soquelitinib for Patients with Autoimmune Lymphoproliferative Syndrome (ALPS)
-
KnowBe4’s KB4-CON 2025 to Spotlight AI's Dual Role in Cybersecurity Threats and Defenses
-
Vera Bradley Announces Fourth Quarter Fiscal Year 2025 Results
-
Global Uranium Commences Geophysical Survey at the Northwest Athabasca Joint Venture Project, Saskatchewan
-
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment
-
NV5 Acquires Herman Cx; Strengthens Domestic Data Center Commissioning Business
-
Inmarsat Verifies Unparalleled 340 Mbps NexusWave Download Speeds to Demonstrate Power of Network Bonding for Maritime Market
-
LiveOne (NASDAQ: LVO) Reaches Milestone: 1.15 Million Subscribers and Ad-Supported Users, Including Tesla
-
Meltwater and NICE partner to bring real-time social Intelligence to customer service
-
FuelCell Energy Participates in Innovation Agora as Part of Annual CERAWeek Conference
-
QuestionPro and MarketCulture Partner to Help Companies Drive Customer-Centricity and Business Growth
-
KnowBe4’s KB4-CON 2025 to Spotlight AI's Dual Role in Cybersecurity Threats and Defenses
-
Solid Biosciences to Present at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
-
Marotta Controls Recognized with Northrop Grumman 2025 Supplier Excellence Award
-
NevGold Defines Significant 2.4 Km Copper, Gold, and Molybdenum Soils Trend At the Zeus Copper Project in the Hercules Copper District, Idaho
-
BD² ANNOUNCES FOUR NEW SITES TO JOIN LANDMARK BIPOLAR DISORDER RESEARCH AND CLINICAL CARE NETWORK
-
Cerro de Pasco Resources Receives Final Approval to List on the TSX Venture Exchange
-
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
-
Media Alert: Audible Presents The Conscious Club
-
8 Rivers and Wood Sign Pre-FEED Agreement for Wyoming Carbon Capture Project
-
Acuity Positioned for Growth and Compounding Value
-
Foremost Clean Energy Announces $6.5 Million Uranium Exploration Program Across the Athabasca Basin
-
Acumen Pharmaceuticals to Present During International Conference on Alzheimer’s and Parkinson’s Diseases 2025 and American Academy of Neurology Annual Meeting
-
YPrime Earns Prestigious EcoVadis Rating, Strengthening Commitment to Sustainable and Responsible Clinical Research
-
President Hilda Heine of the Marshall Islands Joins GCA Advisory Board
-
ZyVersa Therapeutics Highlights Data Demonstrating Inflammasome Inhibition Reduces Neuroinflammation and Pathological Brain Deposition of Amyloid Beta in Alzheimer’s Disease Mouse Model
-
Annual General Meeting 2025 – GN Store Nord A/S
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SERICA ENERGY PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares
-
Alliance Witan PLC - Net Asset Value
-
PyroWorld: The Next Evolution in Hybrid Crypto Exchange – Licensed, Secure, and Expanding with AI & OTC Solutions
-
PyroWorld: The Next Evolution in Hybrid Crypto Exchange – Licensed, Secure, and Expanding with AI & OTC Solutions
-
Stack Capital Group Inc. Reports 2024 Financial Results
-
OBI Pharma Receives ‘Most Promising ADC Clinical Candidate in Taiwan’ Award
-
Prestige Wealth Inc. announces that its subsidiary InnoSphere integrates DeepSeek, accelerating full-scale transformation into AI Fintech
-
FirstService Corporation Announces Upcoming Meeting and Financial Reporting Dates
-
Compass Lexecon Adds Antitrust and Economics Expert William Rogerson
-
American Tungsten Corp. Identifies Principal Exploration Target for the IMA Mine Project in Idaho, USA
-
Montage Gold Reports on Executive Incentive Plan Milestones
-
JOYY to Announce Fourth Quarter and Full Year 2024 Financial Results on March 19, 2025
-
Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall
-
Sagimet Biosciences Reports Full Year 2024 Financial Results and Provides Corporate Updates
-
Kelly to Participate in Sidoti Virtual Investor Conference
-
OptimizeRx Reports Strong Fourth Quarter and Full Year 2024 Financial Results
-
Theratechnologies CROI Presentation Highlights Limitations of Using BMI to Assess Cardiovascular (CV) Risk in People with HIV
-
Theratechnologies Presents Encouraging Virologic Suppression Data from the PROMISE-US Trial of Ibalizumab at CROI
-
Atsena Therapeutics Granted U.S. FDA Fast Track Designation for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis
-
Changes in Marimekko’s management – Paula Ukonaho appointed Marimekko’s Chief Business Development Officer and member of the Management Group
